These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Simulating from marginal structural models with time-dependent confounding. Havercroft WG; Didelez V Stat Med; 2012 Dec; 31(30):4190-206. PubMed ID: 22826156 [TBL] [Abstract][Full Text] [Related]
5. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Hernán MA; Brumback BA; Robins JM Stat Med; 2002 Jun; 21(12):1689-709. PubMed ID: 12111906 [TBL] [Abstract][Full Text] [Related]
6. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Tentori F; Albert JM; Young EW; Blayney MJ; Robinson BM; Pisoni RL; Akiba T; Greenwood RN; Kimata N; Levin NW; Piera LM; Saran R; Wolfe RA; Port FK Nephrol Dial Transplant; 2009 Mar; 24(3):963-72. PubMed ID: 19028748 [TBL] [Abstract][Full Text] [Related]
7. Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models. Kyle RP; Moodie EE; Klein MB; Abrahamowicz M Am J Epidemiol; 2016 Aug; 184(3):249-58. PubMed ID: 27416840 [TBL] [Abstract][Full Text] [Related]
8. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART. Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816 [TBL] [Abstract][Full Text] [Related]
9. Fitting marginal structural models: estimating covariate-treatment associations in the reweighted data set can guide model fitting. Pullenayegum EM; Lam C; Manlhiot C; Feldman BM J Clin Epidemiol; 2008 Sep; 61(9):875-81. PubMed ID: 18486447 [TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR; Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042 [TBL] [Abstract][Full Text] [Related]
11. A set of SAS macros for calculating and displaying adjusted odds ratios (with confidence intervals) for continuous covariates in logistic B-spline regression models. Gregory M; Ulmer H; Pfeiffer KP; Lang S; Strasak AM Comput Methods Programs Biomed; 2008 Oct; 92(1):109-14. PubMed ID: 18603325 [TBL] [Abstract][Full Text] [Related]
12. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200 [TBL] [Abstract][Full Text] [Related]
15. Investigating the effects of the fixed and varying dispersion parameters of Poisson-gamma models on empirical Bayes estimates. Lord D; Park PY Accid Anal Prev; 2008 Jul; 40(4):1441-57. PubMed ID: 18606278 [TBL] [Abstract][Full Text] [Related]
16. Scaled marginal models for multiple continuous outcomes. Roy J; Lin X; Ryan LM Biostatistics; 2003 Jul; 4(3):371-83. PubMed ID: 12925505 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Brumback BA; Hernán MA; Haneuse SJ; Robins JM Stat Med; 2004 Mar; 23(5):749-67. PubMed ID: 14981673 [TBL] [Abstract][Full Text] [Related]
18. Risk factor adjustment in marginal structural model estimation of optimal treatment regimes. Moodie EE Biom J; 2009 Oct; 51(5):774-88. PubMed ID: 19816876 [TBL] [Abstract][Full Text] [Related]
19. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267 [TBL] [Abstract][Full Text] [Related]
20. Systematic differences in treatment effect estimates between propensity score methods and logistic regression. Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH Int J Epidemiol; 2008 Oct; 37(5):1142-7. PubMed ID: 18453634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]